Skip to content

Effects of remote exercise support based on "online exercise prescription" on exercise behavior of patients with hypertension

Effects of remote exercise support based on "online exercise prescription" on exercise behavior of patients with hypertension - Remote exercise rehabilitation for hypertension

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076451
Enrollment
Unknown
Registered
2023-10-09
Start date
2023-10-10
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Intervention group:remote exercise rehabilitation

Sponsors

Zhujiang hospital,Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) According to the hypertension diagnostic criteria in the 2018 Revision of the Chinese Guidelines for the Prevention and Treatment of Hypertension, systolic blood pressure =140 mmHg and/or diastolic blood pressure =90 mmHg, diagnosed as hypertension, and voluntarily participate in the trial and sign the informed consent; (2) Age 18-70; (3) no cognitive impairment or mental illness; (4) Have passed the physical activity preparation questionnaire screening or have been approved by a physician before participating; (5) Able to communicate in normal language and cooperate with questionnaire survey; (6) Not participate in other relevant research involving the promotion of a healthy lifestyle (physical exercise); (7) No exercise habit in the past, that is, exercise frequency <3 times/week, time <30min/ time; (8) Have a smartphone and be able to access wechat and the Internet through a smartphone.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary hypertension; (2) Patients with severe or poorly controlled hypertension (i.e., quiet SBP=180mmHg and/or DBP=110mmHg); (3) Patients with pulmonary hypertension, severe hypertension, hypertensive crisis, unstable stage III hypertension, hypertensive encephalopathy or acute hypertension, or other serious complications, such as severe arrhythmia, tachycardia, heart failure, unstable angina pectoris, the occurrence of obvious adverse reactions to antihypertensive drugs and failure to control; (4) Patients with malignant tumors or hypertension combined with left ventricular ejection fraction less than 55%, combined with aortic, mitral, tricuspid and pulmonary stenosis, combined with severe mitral, tricuspid and pulmonary valve insufficiency, hypertrophic cardiomyopathy, acute infection, fundus hemorrhage, diabetic acidosis, gangrene of lower limbs, severe hypothyroidism, and renal insufficiency. (5) Patients with motor organ injury who underwent bone and joint surgery < 1 year, such as hip, knee replacement, spine surgery, etc. (6) Unable to understand or answer questions or complete questionnaires due to subjective or objective reasons; (7) Participants considered unsuitable for clinical trials by the researchers.

Design outcomes

Primary

MeasureTime frame
6MWT;

Secondary

MeasureTime frame
IPAQ-SF;SF-12;Psychological status;exercise self-efficacy;

Countries

China

Contacts

Public ContactHuang Guozhi

Zhujiang hospital,Southern Medical University

drhuang66@163.com+86 186 6608 7186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026